200 related articles for article (PubMed ID: 28259880)
1. Modified Fluorodeoxyglucose Metabolism in Motor Circuitry by Subthalamic Deep Brain Stimulation.
Cao C; Zhang H; Li D; Zhan S; Zhang J; Zhang X; Zuo C; Sun B
Stereotact Funct Neurosurg; 2017; 95(2):93-101. PubMed ID: 28259880
[TBL] [Abstract][Full Text] [Related]
2. Effects of STN-DBS surgery on cerebral glucose metabolism and distribution of DAT in Parkinson's disease.
Luo G; Shi X; Jiang L; Wu L; Yi C; Xian W; Liu Y; Wen F; Qian H; Chen J; Fu X; Liu J; Zhang X; Chen L
Brain Behav; 2023 Aug; 13(8):e3172. PubMed ID: 37459244
[TBL] [Abstract][Full Text] [Related]
3. Subthalamic nucleus stimulation affects limbic and associative circuits: a PET study.
Le Jeune F; Péron J; Grandjean D; Drapier S; Haegelen C; Garin E; Millet B; Vérin M
Eur J Nucl Med Mol Imaging; 2010 Aug; 37(8):1512-20. PubMed ID: 20349231
[TBL] [Abstract][Full Text] [Related]
4. Effect of STN DBS on vesicular monoamine transporter 2 and glucose metabolism in Parkinson's disease.
Smith GS; Mills KA; Pontone GM; Anderson WS; Perepezko KM; Brasic J; Zhou Y; Brandt J; Butson CR; Holt DP; Mathews WB; Dannals RF; Wong DF; Mari Z
Parkinsonism Relat Disord; 2019 Jul; 64():235-241. PubMed ID: 31053531
[TBL] [Abstract][Full Text] [Related]
5. Subthalamic nucleus stimulation restores glucose metabolism in associative and limbic cortices and in cerebellum: evidence from a FDG-PET study in advanced Parkinson's disease.
Hilker R; Voges J; Weisenbach S; Kalbe E; Burghaus L; Ghaemi M; Lehrke R; Koulousakis A; Herholz K; Sturm V; Heiss WD
J Cereb Blood Flow Metab; 2004 Jan; 24(1):7-16. PubMed ID: 14688612
[TBL] [Abstract][Full Text] [Related]
6. Frontal FDG-PET activity correlates with cognitive outcome after STN-DBS in Parkinson disease.
Kalbe E; Voges J; Weber T; Haarer M; Baudrexel S; Klein JC; Kessler J; Sturm V; Heiss WD; Hilker R
Neurology; 2009 Jan; 72(1):42-9. PubMed ID: 19122029
[TBL] [Abstract][Full Text] [Related]
7. FDG-PET study of the bilateral subthalamic nucleus stimulation effects on the regional cerebral metabolism in advanced Parkinson disease.
Li D; Zuo C; Guan Y; Zhao Y; Shen J; Zan S; Sun B
Acta Neurochir Suppl; 2006; 99():51-4. PubMed ID: 17370764
[TBL] [Abstract][Full Text] [Related]
8. Network modulation in the treatment of Parkinson's disease.
Asanuma K; Tang C; Ma Y; Dhawan V; Mattis P; Edwards C; Kaplitt MG; Feigin A; Eidelberg D
Brain; 2006 Oct; 129(Pt 10):2667-78. PubMed ID: 16844713
[TBL] [Abstract][Full Text] [Related]
9. Network modulation by the subthalamic nucleus in the treatment of Parkinson's disease.
Trost M; Su S; Su P; Yen RF; Tseng HM; Barnes A; Ma Y; Eidelberg D
Neuroimage; 2006 May; 31(1):301-7. PubMed ID: 16466936
[TBL] [Abstract][Full Text] [Related]
10. STN-DBS activates the target area in Parkinson disease: an FDG-PET study.
Hilker R; Voges J; Weber T; Kracht LW; Roggendorf J; Baudrexel S; Hoevels M; Sturm V; Heiss WD
Neurology; 2008 Sep; 71(10):708-13. PubMed ID: 18650492
[TBL] [Abstract][Full Text] [Related]
11. Subthalamic nucleus stimulation affects theory of mind network: a PET study in Parkinson's disease.
Péron J; Le Jeune F; Haegelen C; Dondaine T; Drapier D; Sauleau P; Reymann JM; Drapier S; Rouaud T; Millet B; Vérin M
PLoS One; 2010 Mar; 5(3):e9919. PubMed ID: 20360963
[TBL] [Abstract][Full Text] [Related]
12. Modulation of metabolic brain function by bilateral subthalamic nucleus stimulation in the treatment of Parkinson's disease.
Wang J; Ma Y; Huang Z; Sun B; Guan Y; Zuo C
J Neurol; 2010 Jan; 257(1):72-8. PubMed ID: 19662326
[TBL] [Abstract][Full Text] [Related]
13. Effects of bilateral subthalamic nucleus stimulation on resting-state cerebral glucose metabolism in advanced Parkinson's disease.
Zhao YB; Sun BM; Li DY; Wang QS
Chin Med J (Engl); 2004 Sep; 117(9):1304-8. PubMed ID: 15377418
[TBL] [Abstract][Full Text] [Related]
14. Metabolic correlates of subthalamic nucleus activity in Parkinson's disease.
Lin TP; Carbon M; Tang C; Mogilner AY; Sterio D; Beric A; Dhawan V; Eidelberg D
Brain; 2008 May; 131(Pt 5):1373-80. PubMed ID: 18400841
[TBL] [Abstract][Full Text] [Related]
15. Subthalamic nucleus stimulation in Parkinson disease induces apathy: a PET study.
Le Jeune F; Drapier D; Bourguignon A; Péron J; Mesbah H; Drapier S; Sauleau P; Haegelen C; Travers D; Garin E; Malbert CH; Millet B; Vérin M
Neurology; 2009 Nov; 73(21):1746-51. PubMed ID: 19933975
[TBL] [Abstract][Full Text] [Related]
16. Brain energization in response to deep brain stimulation of subthalamic nuclei in Parkinson's disease.
Garraux G; Bahri MA; Lemaire C; Degueldre C; Salmon E; Kaschten B
J Cereb Blood Flow Metab; 2011 Jul; 31(7):1612-22. PubMed ID: 21468092
[TBL] [Abstract][Full Text] [Related]
17. Frequency-correlated decreases of motor cortex activity associated with subthalamic nucleus stimulation in Parkinson's disease.
Haslinger B; Kalteis K; Boecker H; Alesch F; Ceballos-Baumann AO
Neuroimage; 2005 Nov; 28(3):598-606. PubMed ID: 16081302
[TBL] [Abstract][Full Text] [Related]
18. Effects of Subthalamic Stimulation on Olfactory Function in Parkinson Disease.
Cury RG; Carvalho MJ; Lasteros FJL; Dias AE; Dos Santos Ghilardi MG; Paiva ARB; Coutinho AM; Buchpiguel CA; Teixeira MJ; Barbosa ER; Fonoff ET
World Neurosurg; 2018 Jun; 114():e559-e564. PubMed ID: 29548954
[TBL] [Abstract][Full Text] [Related]
19. Attenuation of fluctuating striatal synaptic dopamine levels in patients with Parkinson disease in response to subthalamic nucleus stimulation: a positron emission tomography study.
Nimura T; Yamaguchi K; Ando T; Shibuya S; Oikawa T; Nakagawa A; Shirane R; Itoh M; Tominaga T
J Neurosurg; 2005 Dec; 103(6):968-73. PubMed ID: 16381182
[TBL] [Abstract][Full Text] [Related]
20. Pre-frontal-insular-cerebellar modifications correlate with disgust feeling blunting after subthalamic stimulation: A positron emission tomography study in Parkinson's disease.
Ory S; Le Jeune F; Haegelen C; Vicente S; Philippot P; Dondaine T; Jannin P; Drapier S; Drapier D; Sauleau P; Vérin M; Péron J
J Neuropsychol; 2017 Sep; 11(3):378-395. PubMed ID: 26670087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
